Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CAP, Adenylate Cyclase-Associated Protein 1 (CAP1) (N-Term) Peptid

CAP1 Wirt: Synthetic BP, WB
Produktnummer ABIN8096132
168,15 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für CAP, Adenylate Cyclase-Associated Protein 1 (CAP1) (N-Term) Peptid (ABIN8096132)

Target

CAP1 (CAP, Adenylate Cyclase-Associated Protein 1 (CAP1))

Quelle

  • 6
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    N-Term

    Verwendungszweck

    CAP1 Peptide - N-terminal region
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Kommentare

    This is a synthetic peptide designed for use in combination with anti-CAP1 antibody ( ARP48295_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Target

    CAP1 (CAP, Adenylate Cyclase-Associated Protein 1 (CAP1))

    Hintergrund

    Background Information: The protein encoded by this gene is related to the S. cerevisiae CAP protein, which is involved in the cyclic AMP pathway. The human protein is able to interact with other molecules of the same protein, as well as with CAP2 and actin. Alternatively splice

    Alternative Symbols: CAP, CAP1-PEN

    Molekulargewicht

    52kDa

    Gen-ID

    10487

    NCBI Accession

    NP_006358

    UniProt

    Q01518
Sie sind hier:
Chat with us!